The Scientist Behind Moderna on How Engineering Revolutionizes Medicine
[HPP] Robert LangerFebruary 4, 202638 min
45 connectionsΒ·40 entities in this videoβPioneering Bioengineering & Persistence
- π‘ Dr. Robert Langer, a founding figure in bioengineering and one of the most cited scientists, discussed his career and the role of engineering in medicine.
- π― Despite numerous job and grant rejections early on, he persisted, driven by a belief in his work and a commitment to solving important problems.
- π¬ His lab at MIT is one of the largest in the world, focusing on biotechnology and science, and he views the success of his students as his proudest achievement.
Revolutionizing Drug Delivery
- π Langer's early work involved developing nanoparticles for delivering large molecules like proteins, RNA, and DNA, a feat once considered impossible.
- β This breakthrough, published in 1976, laid the foundation for modern nucleic acid delivery systems and was achieved after 200 failed attempts.
- π He also pioneered degradable polymers for medical use, leading to an FDA-approved brain implant for local chemotherapy in cancer patients, which has been used in over 10 million patients.
The Moderna Story & mRNA Vaccines
- 𧬠Langer co-founded Moderna, building on the concept of using messenger RNA (mRNA) for therapeutic purposes, leveraging his lab's advancements in nanoparticles and lipids.
- π mRNA vaccines work by delivering RNA in nanoparticles, prompting cells to produce a specific protein (e.g., COVID spike protein), which then trains the immune system to attack it.
- β‘ This technology enabled rapid vaccine design and development during the COVID-19 pandemic, saving millions of lives and preventing hospitalizations.
- π Future applications include more effective flu vaccines, potential HIV vaccines, and personalized cancer treatments based on tumor mutations.
Advanced Medical Engineering Applications
- π οΈ His lab's work extends to tissue engineering, creating artificial skin for burn victims and FDA-approved synthetic blood vessels used to treat soldiers.
- π§ Organs-on-chips are being developed to mimic human biology for faster drug testing and reduced reliance on animal models, a concept the FDA is exploring.
- π‘ Ongoing challenges in drug delivery include targeting specific cells (like cancer cells) and overcoming biological barriers (e.g., blood-brain barrier, oral delivery).
Innovations in Diabetes & AI
- π¬ Research in diabetes includes developing an artificial pancreas by encapsulating islet cells and creating materials to prevent fibrous tissue encapsulation.
- π A novel oral insulin delivery system in pill form, which injects directly into the stomach, is being developed and tested for safety in humans.
- π€ Artificial intelligence (AI) has long been used in his work for high-throughput screening, optimizing drug solubility, and designing better lipid nanoparticles and nutrition systems, such as iron delivery for the developing world.
Future Outlook
- π Langer believes science always wins and anticipates significant advancements in treatments for cancer, brain diseases, and heart disease through continued engineering innovation.
- π¬ He addresses misconceptions about mRNA vaccines, attributing them to misinformation and communication issues, but remains optimistic about scientific progress.
Knowledge graph40 entities Β· 45 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
40 entities
Chapters11 moments
Key Moments
Transcript139 segments
Full Transcript
Topics15 themes
Whatβs Discussed
BioengineeringDrug DeliveryNanoparticlesmRNA VaccinesModernaTissue EngineeringArtificial SkinSynthetic Blood VesselsOrgans-on-ChipsPersonalized Cancer TreatmentsDiabetes TreatmentArtificial PancreasOral Insulin DeliveryArtificial Intelligence (AI)Lipid Nanoparticles
Smart Objects40 Β· 45 links
PeopleΒ· 10
CompaniesΒ· 7
ConceptsΒ· 13
ProductsΒ· 9
EventΒ· 1